Literature DB >> 16829550

Measuring changes in functional status among patients with schizophrenia: the link with cognitive impairment.

Louis S Matza1, Robert Buchanan, Scot Purdon, Jessica Brewster-Jordan, Yang Zhao, Dennis A Revicki.   

Abstract

Cognitive impairment associated with schizophrenia (CIAS) includes neuropsychological deficits in attention, working memory, verbal learning, and problem solving. These deficits have been shown to be linked to impairment in functional status (eg, social behavior, work performance, and activities of daily living) among patients with schizophrenia in cross-sectional studies. Less is known about the relationship between cognitive and functional change over time, such as potential functional implications of treatment-related improvement in CIAS. The purpose of this review is to summarize research on the association between change in CIAS and change in functional status, to discuss responsiveness of functional outcomes measures, and to provide recommendations for future research and measure development. Nine longitudinal studies were located on the link between CIAS and functional status, and 8 functional outcomes measures were used across these studies. The 9 studies offer initial support for a link between change in cognitive function and change in functional status. However, inconsistent findings across studies indicate that available research is preliminary, and substantial questions remain unanswered. Shortcomings of functional status measures are noted: most instruments were not developed for the target population, and none have demonstrated responsiveness to cognitive change among schizophrenic patients. It is recommended that new functional outcome measures be developed that are specifically designed to be responsive to change in cognition, with domains previously shown to be related to cognitive ability. When creating new functional outcomes measures for assessment of patients with schizophrenia, responsiveness to change in CIAS should be evaluated as part of the development and validation process.

Entities:  

Mesh:

Year:  2006        PMID: 16829550      PMCID: PMC2632260          DOI: 10.1093/schbul/sbl004

Source DB:  PubMed          Journal:  Schizophr Bull        ISSN: 0586-7614            Impact factor:   9.306


  78 in total

1.  Atypical antipsychotics and cognition in schizophrenia.

Authors:  Tonmoy Sharma
Journal:  Arch Gen Psychiatry       Date:  2002-06

2.  UCSD Performance-Based Skills Assessment: development of a new measure of everyday functioning for severely mentally ill adults.

Authors:  T L Patterson; S Goldman; C L McKibbin; T Hughs; D V Jeste
Journal:  Schizophr Bull       Date:  2001       Impact factor: 9.306

Review 3.  Assessing meaningful change in quality of life over time: a users' guide for clinicians.

Authors:  Mirjam A G Sprangers; Carol M Moinpour; Timothy J Moynihan; Donald L Patrick; Dennis A Revicki
Journal:  Mayo Clin Proc       Date:  2002-06       Impact factor: 7.616

4.  Recommendations for evaluating the validity of quality of life claims for labeling and promotion.

Authors:  N K Leidy; D A Revicki; B Genesté
Journal:  Value Health       Date:  1999 Mar-Apr       Impact factor: 5.725

5.  Assessing the responsiveness of functional scales to clinical change: an analogy to diagnostic test performance.

Authors:  R A Deyo; R M Centor
Journal:  J Chronic Dis       Date:  1986

6.  Generalized cognitive deficits in schizophrenia: a study of first-episode patients.

Authors:  S Mohamed; J S Paulsen; D O'Leary; S Arndt; N Andreasen
Journal:  Arch Gen Psychiatry       Date:  1999-08

Review 7.  Methods to explain the clinical significance of health status measures.

Authors:  Gordon H Guyatt; David Osoba; Albert W Wu; Kathleen W Wyrwich; Geoffrey R Norman
Journal:  Mayo Clin Proc       Date:  2002-04       Impact factor: 7.616

8.  Reliable self-report of health service use by individuals with serious mental illness.

Authors:  Richard W Goldberg; Diana C Seybolt; Anthony Lehman
Journal:  Psychiatr Serv       Date:  2002-07       Impact factor: 3.084

9.  The functional consequences of memory impairments on initial work performance in people with schizophrenia.

Authors:  G Bryson; M D Bell; E Kaplan; T Greig
Journal:  J Nerv Ment Dis       Date:  1998-10       Impact factor: 2.254

Review 10.  Cognitive functioning in schizophrenia: a consensus statement on its role in the definition and evaluation of effective treatments for the illness.

Authors:  Philip D Harvey; Michael F Green; Richard S E Keefe; Dawn I Velligan
Journal:  J Clin Psychiatry       Date:  2004-03       Impact factor: 4.384

View more
  21 in total

1.  An open-label, prospective study to evaluate social function and overall improvement of extended-release paliperidone treatment in Thai schizophrenia patients.

Authors:  Chawanun Charnsil; Salinee Vongpanich
Journal:  Neuropsychiatr Dis Treat       Date:  2013-08-20       Impact factor: 2.570

2.  Progress on NIMH initiatives (memorial theme for Wayne Fenton, MD).

Authors:  Ellen Stover; Steve Marder; William Carpenter
Journal:  Schizophr Bull       Date:  2007-07-19       Impact factor: 9.306

3.  Cognitive performance and functional competence as predictors of community independence in schizophrenia.

Authors:  R Walter Heinrichs; Narmeen Ammari; Ashley A Miles; Stephanie McDermid Vaz
Journal:  Schizophr Bull       Date:  2008-07-30       Impact factor: 9.306

4.  Impaired associative inference in patients with schizophrenia.

Authors:  Kristan Armstrong; Samet Kose; Lisa Williams; Austin Woolard; Stephan Heckers
Journal:  Schizophr Bull       Date:  2010-12-06       Impact factor: 9.306

5.  Cognitive efficacy of quetiapine and olanzapine in early-onset first-episode psychosis.

Authors:  Olalla Robles; Arantzazu Zabala; Igor Bombín; Mara Parellada; Dolores Moreno; Ana Ruiz-Sancho; Celso Arango
Journal:  Schizophr Bull       Date:  2009-08-25       Impact factor: 9.306

6.  Illness-related components for the family burden of relatives to patients with psychotic illness.

Authors:  Fredrik Hjärthag; Lars Helldin; Ulla Karilampi; Torsten Norlander
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2009-05-19       Impact factor: 4.328

Review 7.  The evolution of drug development in schizophrenia: past issues and future opportunities.

Authors:  William T Carpenter; James I Koenig
Journal:  Neuropsychopharmacology       Date:  2007-11-28       Impact factor: 7.853

8.  Long-term Changes in Cognitive Functioning in Individuals With Psychotic Disorders: Findings From the Suffolk County Mental Health Project.

Authors:  Anne-Kathrin J Fett; Eva Velthorst; Abraham Reichenberg; Camilo J Ruggero; Jennifer L Callahan; Laura J Fochtmann; Gabrielle A Carlson; Greg Perlman; Evelyn J Bromet; Roman Kotov
Journal:  JAMA Psychiatry       Date:  2020-04-01       Impact factor: 21.596

9.  The importance of measuring psychosocial functioning in schizophrenia.

Authors:  Sofia Brissos; Andrew Molodynski; Vasco Videira Dias; Maria Luísa Figueira
Journal:  Ann Gen Psychiatry       Date:  2011-06-24       Impact factor: 3.455

10.  Clinical usefulness of the screen for cognitive impairment in psychiatry (SCIP-S) scale in patients with type I bipolar disorder.

Authors:  Georgina Guilera; Oscar Pino; Juana Gómez-Benito; J Emilio Rojo; Eduard Vieta; Rafael Tabarés-Seisdedos; Nuria Segarra; Anabel Martínez-Arán; Manuel Franco; Manuel J Cuesta; Benedicto Crespo-Facorro; Miguel Bernardo; Scot E Purdon; Teresa Díez; Javier Rejas
Journal:  Health Qual Life Outcomes       Date:  2009-04-01       Impact factor: 3.186

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.